
Chemicals & Petrochemicals
Valuation | |
|---|---|
| Market Cap | 21.66 kCr |
| Price/Earnings (Trailing) | 40.62 |
| Price/Sales (Trailing) | 2.7 |
| EV/EBITDA | 23.16 |
| Price/Free Cashflow | -48.79 |
| MarketCap/EBT | 29.5 |
| Enterprise Value | 22.79 kCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 8.02 kCr |
| Rev. Growth (Yr) | 3.1% |
| Earnings (TTM) | 533.32 Cr |
| Earnings Growth (Yr) | 1.7% |
Profitability | |
|---|---|
| Operating Margin | 9% |
| EBT Margin | 9% |
| Return on Equity | 9.61% |
| Return on Assets | 6.77% |
| Free Cashflow Yield | -2.05% |
Growth & Returns | |
|---|---|
| Price Change 1W | -3.8% |
| Price Change 1M | 1.6% |
| Price Change 6M | -12.2% |
| Price Change 1Y | -18.5% |
| 3Y Cumulative Return | -4.3% |
| 5Y Cumulative Return | 2.6% |
| 7Y Cumulative Return | 32.4% |
| 10Y Cumulative Return | 38.8% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -1.49 kCr |
| Cash Flow from Operations (TTM) | 624.7 Cr |
| Cash Flow from Financing (TTM) | 806.16 Cr |
| Cash & Equivalents | 22.5 Cr |
| Free Cash Flow (TTM) | -497.37 Cr |
| Free Cash Flow/Share (TTM) | -36.47 |
Balance Sheet | |
|---|---|
| Total Assets | 7.88 kCr |
| Total Liabilities | 2.33 kCr |
| Shareholder Equity | 5.55 kCr |
| Current Assets | 2.8 kCr |
| Current Liabilities | 887.36 Cr |
| Net PPE | 2.51 kCr |
| Inventory | 903.77 Cr |
| Goodwill | 2.66 Cr |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.15 |
| Debt/Equity | 0.21 |
| Interest Coverage | 19.15 |
| Interest/Cashflow Ops | 21.91 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 7.5 |
| Dividend Yield | 0.46% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | 0.00% |
Smart Money: Smart money has been increasing their position in the stock.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Size: Market Cap wise it is among the top 20% companies of india.
Balance Sheet: Strong Balance Sheet.
Momentum: Stock has a weak negative price momentum.
Technicals: SharesGuru indicator is Bearish.
Past Returns: Underperforming stock! In past three years, the stock has provided -4.3% return compared to 13.3% by NIFTY 50.
Growth: Poor revenue growth. Revenue grew at a disappointing -3.4% on a trailing 12-month basis.
Smart Money: Smart money has been increasing their position in the stock.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Size: Market Cap wise it is among the top 20% companies of india.
Balance Sheet: Strong Balance Sheet.
Momentum: Stock has a weak negative price momentum.
Technicals: SharesGuru indicator is Bearish.
Past Returns: Underperforming stock! In past three years, the stock has provided -4.3% return compared to 13.3% by NIFTY 50.
Growth: Poor revenue growth. Revenue grew at a disappointing -3.4% on a trailing 12-month basis.
Investor Care | |
|---|---|
| Dividend Yield | 0.46% |
| Dividend/Share (TTM) | 7.5 |
| Shares Dilution (1Y) | 0.00% |
| Earnings/Share (TTM) | 39.1 |
Financial Health | |
|---|---|
| Current Ratio | 3.16 |
| Debt/Equity | 0.21 |
Technical Indicators | |
|---|---|
| RSI (14d) | 43.81 |
| RSI (5d) | 46.48 |
| RSI (21d) | 51.58 |
| MACD Signal | Sell |
| Stochastic Oscillator Signal | Hold |
| SharesGuru Signal | Sell |
| RSI Signal | Hold |
| RSI5 Signal | Hold |
| RSI21 Signal | Hold |
| SMA 5 Signal | Sell |
| SMA 10 Signal |
Updated May 5, 2025
Despite the recent increase, Deepak Nitrite has underperformed this year with a -20.23% return.
Deepak Chemtex has declined by 13.02% over the last three months, reflecting a challenging market environment.
Foreign Institutional Investor holdings in Deepak Nitrite have decreased to 6.59%, indicating reduced foreign interest.
Summary of Deepak Nitrite's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
In the recent earnings conference call for Q3 & 9M FY26, Management provided an optimistic yet cautious outlook for Deepak Nitrite Limited. Key highlights included a consolidated total revenue of INR 1,983 crore for Q3, marking a 3% growth year-on-year and quarter-on-quarter. EBITDA rose by 16% to INR 219 crore, reflecting improved operational efficiencies amid pricing pressures. For the nine-month period, consolidated revenue reached INR 5,820 crore and EBITDA stood at INR 658 crore.
Management discussed resilience in navigating a challenging operational landscape characterized by global competitive pressures, particularly from Chinese producers. They highlighted that the long-term growth strategy focuses on value chain integration and expansion into specialty products. Major milestones included the commissioning of new capabilities such as nitric acid production and nitration/hydrogenation plants expected to enhance raw material security and margin stability.
A successful launch of the MIBK/MIBC project is anticipated within the current quarter, alongside ongoing preparations for India's first integrated propylene to polycarbonate manufacturing facility. Noteworthy is the positive international tariff policy shifts, particularly the U.S. India tariff adjustments and the removal of anti-dumping duties on sodium nitrite exports, which historically accounted for approximately 5,000 tonnes/year.
Management underscored that Q4 FY26 is anticipated to outperform Q3 due to improved demand dynamics, waning competitive pressures, and recent strategic product innovations. The company aims for a consolidated return on capital employed (ROCE) of around 15%, supported by robust financial health and efficient capital allocation.
In brief, while the short-term outlook remains cautious due to ongoing global dynamics, management expects medium-to-long-term opportunities from international trade agreements and sustained operational execution.
Understand Deepak Nitrite ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| Deepak Chimanlal Mehta | 16.56% |
| Life Insurance Corporation Of India | 9.47% |
| Stiffen Credits And Capital Pvt Ltd | 6.19% |
| Checkpoint Credits And Capital Pvt Ltd | 5.28% |
| Stepup Credits And Capital Pvt Ltd | 5.08% |
| Stigma Credits And Capital P Ltd | 4.54% |
| Deepak Novochem Technologies Limited |
Detailed comparison of Deepak Nitrite against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Comprehensive comparison against sector averages
DEEPAKNTR metrics compared to Chemicals
| Category | DEEPAKNTR | Chemicals |
|---|---|---|
| PE | 41.35 | 43.96 |
| PS | 2.75 | 4.07 |
| Growth | -3.4 % | 7.2 % |
Deepak Nitrite is a Specialty Chemicals company based in India, with the stock ticker DEEPAKNTR. The company has a market capitalization of Rs. 26,978.5 Crores.
It specializes in the manufacturing, trading, and sale of chemical intermediates both domestically and internationally. Deepak Nitrite operates through two segments: Advanced Intermediates and Phenolics.
The product portfolio includes a wide range of chemicals such as:
These products cater to various industries including colourants, dyes, rubber, paper, agrochemicals, pharmaceuticals, personal care, water treatment, glass, explosives, and textiles.
Furthermore, Deepak Nitrite provides essential chemicals like:
These are applied in areas such as laminate and plywood, automotive, construction, pharmaceuticals, adhesives, sanitizers, rubber, chemicals, and paints.
The company also offers various specialty products and services, including project engineering, procurement, construction, commissioning, management, and consultancy services.
Incorporated in 1970 and headquartered in Vadodara, India, Deepak Nitrite has demonstrated strong performance with a trailing 12 months revenue of Rs. 8,308.7 Crores. It also distributes dividends to its investors with a yield of 0.34% per year, having returned Rs. 7.5 dividend per share in the last 12 months. The company has achieved 29% revenue growth over the past three years.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
| Sell |
| SMA 20 Signal | Sell |
| SMA 50 Signal | Sell |
| SMA 100 Signal | Sell |
DEEPAKNTR vs Chemicals (2021 - 2026)
Deepak Nitrite's stock is currently trading 2.97% higher at Rs 1,989.35, indicating a positive movement.
General • 23 Feb 2026 Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 |
Earnings Call Transcript • 18 Feb 2026 Submission of Earnings concall Transcript |
General • 13 Feb 2026 Submission of Audio Recording of Earnings Conference Call |
General • 12 Feb 2026 Amendment to the Code of Practices and Procedures for Fair Disclosure of UPSI |
General • 12 Feb 2026 Limited Review Report on Un-audited Financial Results for the quarter and nine months period ended December 31, 2025 with UDIIN |
Investor Presentation • 12 Feb 2026 Q3 AND 9M FY2026 Investor Presentation |
This information is AI-generated and may contain inaccuracies. Please verify from multiple sources.
Q1: "How many products would be coming up? Where are we in terms of these products with the customers, the user industries/applications? And if possible, the size of revenue which Company is expecting from these products put together?"
I shared that we have a pipeline of about 15 products in various stages of development"”R&D, piloting, and awaiting customer feedback. Key application sectors include mining chemicals, flame retardants, personal care, flavors and fragrances, and polymers. We aim to start commercializing several of these in the first half of FY27, contingent on passing validation cycles and customer requirements.
Q2: "What volumes were we exporting before and after the tariffs on sodium nitrite?"
Historically, our exports to the U.S. were about 5,000 tonnes per year. The previous tariff overhang included a nearly 105% combined tax, which has now been significantly reduced. With the tariff removal, we're actively engaging with customers to recapture our market role in sodium nitrite consumption in the U.S.
Q3: "How do you see the opportunity from the EU trade deal, particularly concerning product exports?"
The EU-India FTA requires ratification and will take 6-8 months. While it benefits exports, it mainly opens opportunities for EU firms to export to India. We look forward to procuring raw materials from Europe with removed duties. Indian businesses, including ours, stand to gain from reduced trade barriers, enhancing overall competitiveness in various sectors.
Q4: "When can we expect the full benefit of nitric acid in operational numbers?"
We commissioned the nitric acid plant in mid-December 2025. The current quarter and the next will see nearly 100% utilization. There were delays due to the separation of our nitric acid and nitration plant commissions but both are operational now, setting the stage for improved performance.
Q5: "Can you help us understand which product category has seen significant margin compression?"
The major pinch points were due to delayed antidumping announcements affecting pricing and increased costs from procuring necessary raw materials at spot prices. The decision to aggressively place products led to a temporary margin pressure. We're optimistic for recovery in Q4 FY26 driven by improved integration and operational effectiveness.
Q6: "What green shoots are we seeing for Q4 FY26?"
We expect margins to return to normal levels aided by our integration. Demand is showing improvement in sectors like agrochemicals, mining chemicals, explosives, and polymers. Our domestic phenol demand remains robust. The strategic trade agreements and integration benefits lay a positive outlook moving forward.
Q7: "How are we managing the favorable pricing environment amidst the oversupply issue?"
While pricing pressures exist due to global oversupply, our strategy was to maintain market presence, even if it led to short-term pricing drops. We are collaborating with customers to optimize pricing while focusing on quality and consistency as we move forward into subsequent quarters.
Q8: "What is the CAPEX for FY26 and FY27?"
Our CAPEX for FY27 is around INR 2,500 crore. For FY26, we've already spent around INR 100 crore, bringing the total expected spending to approximately INR 1,200"“1,300 crore.
Q9: "Can you provide insights into the disconnect between phenol spreads and gross margins?"
Phenol spreads are based on international indices, whereas our margins reflect our strategic procurement advantages and increased capacity utilization. We leverage our position in the Indian market, which allows us to maintain better margins despite global spread fluctuations.
Q10: "Have we started manufacturing BPF and using in-house nitric acid?"
We began manufacturing nitric acid in December 2025, and we anticipate being close to 100% self-sufficient in our requirements. For BPF production using BTC, fluorination has been commissioned but we're still troubleshooting quality. We expect to ramp up from Q1 FY27 onwards.
| 3.41% |
| Kotak Midcap Fund | 3.18% |
| Skyrose Finvest Pvt Ltd | 2.81% |
| Franklin India Small Cap Fund | 2.63% |
| Pranawa Leafin Pvt Ltd | 1.69% |
| Forex Leafin Pvt Ltd | 1.59% |
| Icici Prudential Multicap Fund | 1.09% |
| Storewell Credits And Capital Private Ltd | 0.65% |
| Sundown Finvest Pvt Ltd | 0.61% |
| Ila Deepak Mehta | 0.44% |
| Hardik Leafin Pvt Ltd | 0.25% |
| Maulik Deepak Mehta | 0.1% |
| Prahaan Maulik Mehta | 0.03% |
| Aadya Meghav Mehta | 0.03% |
Distribution across major stakeholders
Distribution across major institutional holders
| +19.20% |
| 27.71 |
| 4.45 |
| - |
| - |
| ATUL | Atul | 19.04 kCr | 6.22 kCr | +11.00% | +18.50% | 32.04 | 3.06 | - | - |
| AARTIIND | Aarti Industries | 16.31 kCr | 8.05 kCr | +27.50% | +10.70% | 57.89 | 2.03 | - | - |
| VINATIORGA | Vinati Organics | 15.6 kCr | 2.31 kCr | -1.00% | -2.30% | 35.22 | 6.75 | - | - |
| ALKYLAMINE | Alkyl Amines Chemicals | 7.65 kCr | 1.57 kCr | -4.20% | -8.10% | 42.35 | 4.88 | - | - |
| BALAMINES | Balaji Amines | 3.51 kCr | 1.41 kCr | -4.20% | -22.10% | 24.45 | 2.48 | - | - |
| 4.2% |
| 1,833 |
| 1,759 |
| 1,760 |
| 1,924 |
| 1,789 |
| 1,789 |
| Profit Before exceptional items and Tax | -7.4% | 151 | 163 | 155 | 279 | 135 | 264 |
| Exceptional items before tax | - | -12.84 | 0 | 0 | 0 | 0 | 0 |
| Total profit before tax | -15.4% | 138 | 163 | 155 | 279 | 135 | 264 |
| Current tax | -2.4% | 41 | 42 | 42 | 46 | 37 | 71 |
| Deferred tax | -395.2% | -3.34 | 2.47 | 0.58 | 30 | 0.04 | -1.18 |
| Total tax | -14% | 38 | 44 | 42 | 76 | 37 | 70 |
| Total profit (loss) for period | -16.1% | 100 | 119 | 112 | 202 | 98 | 194 |
| Other comp. income net of taxes | 111% | 1.4 | -2.65 | -0.67 | -1.6 | -0.71 | -0.56 |
| Total Comprehensive Income | -13% | 101 | 116 | 112 | 201 | 97 | 194 |
| Earnings Per Share, Basic | -18% | 7.32 | 8.71 | 8.23 | 14.84 | 7.19 | 14.24 |
| Earnings Per Share, Diluted | -18% | 7.32 | 8.71 | 8.23 | 14.84 | 7.19 | 14.24 |
| 10% |
| 275 |
| 250 |
| 230 |
| 197 |
| 181 |
| 175 |
| Finance costs | 155% | 3.78 | 2.09 | 1.57 | 1.6 | 4.12 | 20 |
| Depreciation and Amortization | 15.1% | 100 | 87 | 76 | 73 | 67 | 78 |
| Other expenses | 4.6% | 552 | 528 | 548 | 448 | 321 | 370 |
| Total Expenses | -1.4% | 2,338 | 2,370 | 2,525 | 1,940 | 1,344 | 1,531 |
| Profit Before exceptional items and Tax | -29.4% | 338 | 478 | 610 | 642 | 479 | 706 |
| Exceptional items before tax | -101.3% | 0 | 80 | 0 | 0 | 0 | 0 |
| Total profit before tax | -39.5% | 338 | 558 | 610 | 642 | 479 | 706 |
| Current tax | -52.7% | 62 | 130 | 134 | 153 | 123 | 192 |
| Deferred tax | 62.5% | -1.27 | -5.06 | 6.73 | 3.28 | 0.67 | -30.09 |
| Total tax | -51.6% | 61 | 125 | 140 | 156 | 124 | 162 |
| Total profit (loss) for period | -36.3% | 276 | 433 | 469 | 486 | 355 | 544 |
| Other comp. income net of taxes | -20.3% | -2.2 | -1.66 | -4.85 | 0.06 | -1.3 | -3.66 |
| Total Comprehensive Income | -36.7% | 274 | 432 | 465 | 486 | 353 | 540 |
| Earnings Per Share, Basic | -37.4% | 20.27 | 31.78 | 34.41 | 35.65 | 26.01 | 39.89 |
| Earnings Per Share, Diluted | -37.4% | 20.27 | 31.78 | 34.41 | 35.65 | 26.01 | 39.89 |
| Debt equity ratio | - | - | - | - | - | - | 014 |
| Debt service coverage ratio | - | - | - | - | - | - | 0.0603 |
| Interest service coverage ratio | - | - | - | - | - | - | 0.4191 |
| 4% |
| 931 |
| 895 |
| 882 |
| 833 |
| 750 |
| 726 |
| Capital work-in-progress | -11.2% | 151 | 170 | 105 | 126 | 114 | 77 |
| Non-current investments | 7.6% | 1,382 | 1,284 | 1,040 | 855 | 799 | 688 |
| Loans, non-current | -245.7% | 0.49 | 1.35 | 1.69 | 1.54 | 0.84 | 0.7 |
| Total non-current financial assets | 7.7% | 1,393 | 1,293 | 1,046 | 860 | 806 | 694 |
| Total non-current assets | 5.3% | 2,497 | 2,372 | 2,047 | 1,831 | 1,693 | 1,523 |
| Total assets | 0.1% | 3,620 | 3,617 | 3,503 | 3,371 | 3,172 | 3,050 |
| Total non-current financial liabilities | 0% | 29 | 29 | 30 | 30 | 2.3 | 10 |
| Provisions, non-current | 12.9% | 36 | 32 | 31 | 29 | 29 | 26 |
| Total non-current liabilities | 9% | 122 | 112 | 110 | 108 | 83 | 93 |
| Borrowings, current | -77.6% | 5.04 | 19 | 19 | 0 | 5.67 | 0 |
| Total current financial liabilities | -15.8% | 295 | 350 | 306 | 271 | 291 | 306 |
| Provisions, current | -6.2% | 16 | 17 | 13 | 17 | 13 | 14 |
| Current tax liabilities | 0% | 1.98 | 1.98 | 5.02 | 7.39 | 0 | 0 |
| Total current liabilities | -12.4% | 332 | 379 | 337 | 308 | 323 | 331 |
| Total liabilities | -7.3% | 455 | 491 | 446 | 416 | 407 | 425 |
| Equity share capital | 0% | 27 | 27 | 27 | 27 | 27 | 27 |
| Total equity | 1.2% | 3,165 | 3,126 | 3,057 | 2,955 | 2,765 | 2,625 |
| Total equity and liabilities | 0.1% | 3,620 | 3,617 | 3,503 | 3,371 | 3,172 | 3,050 |
| -48.4% |
| 64 |
| 123 |
| 139 |
| 152 |
| - |
| - |
| Net Cashflows From Operating Activities | -39.3% | 254 | 418 | 310 | 228 | - | - |
| Cashflows used in obtaining control of subsidiaries | 157.8% | 429 | 167 | 216 | 196 | - | - |
| Proceeds from sales of PPE | 627.3% | 17 | 3.2 | 0.86 | 118 | - | - |
| Purchase of property, plant and equipment | 1% | 210 | 208 | 125 | 104 | - | - |
| Purchase of intangible assets | -209.4% | 0.65 | 1.32 | 1.15 | 0.31 | - | - |
| Cash receipts from repayment of advances and loans made to other parties | 10.8% | 175 | 158 | 0 | 0 | - | - |
| Dividends received | 29.3% | 98 | 76 | 62 | 39 | - | - |
| Interest received | -16.4% | 7.77 | 9.1 | 0.53 | 0.55 | - | - |
| Net Cashflows From Investing Activities | -112.2% | -332.53 | -156.16 | -188.47 | -159.13 | - | - |
| Proceeds from borrowings | - | 19 | 0 | -13.99 | 14 | - | - |
| Payments of lease liabilities | -88.2% | 1.16 | 2.36 | 0 | 0 | - | - |
| Dividends paid | 0% | 102 | 102 | 95 | 75 | - | - |
| Interest paid | 1843.7% | 3.79 | 0.84 | 0.32 | 1.61 | - | - |
| Other inflows (outflows) of cash | 2% | 0.01 | -0.01 | -0.01 | 0 | - | - |
| Net Cashflows from Financing Activities | 16.1% | -88.37 | -105.5 | -112.83 | -64.36 | - | - |
| Net change in cash and cash eq. | -207.6% | -166.82 | 157 | 8.71 | 4.38 | - | - |
General • 09 Feb 2026 Schedule of Q3 & 9M FY 20226 Earnings Conference Call |
Analysis of Deepak Nitrite's financial performance, highlighting revenue trends, growth patterns, and key metrics through quarterly analysis.
Last Updated: Dec 31, 2025
| Description | Share | Value |
|---|---|---|
| Phenolics | 67.2% | 1.3 kCr |
| Advanced Intermediates | 32.8% | 652.5 Cr |
| Total | 2 kCr |
High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years